<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Rockwell Medical, Inc.

    Rockwell Medical, Inc.

    Rockwell Medical (NASDAQ: RMTI) is a fully-integrated biopharmaceutical company ta...

    Rockwell Medical (NASDAQ: RMTI) is a fully-inte...

    Filing Type:    PU
    Akebia Therapeutics, Inc.

    Akebia Therapeutics, Inc.

    We are a fully integrated biopharmaceutical company focused on the development and...

    We are a fully integrated biopharmaceutical com...

    Filing Type:    PU
    HeartIn, Inc

    HeartIn, Inc

    Founded in 2014 in Miami, Florida, HeartIn Inc. is constantly driving innovations ...

    Founded in 2014 in Miami, Florida, HeartIn Inc....

    Amount Raised:    $18,137.00
    Fundraising Status:    EC
    Filing Type:    CF
    Quadrant Biosciences Inc

    Quadrant Biosciences Inc

    Quadrant Biosciences is an epigenetic diagnostics company with a focus on the earl...

    Quadrant Biosciences is an epigenetic diagnosti...

    Filing Type:    RA
    Wuxi Biologics (Cayman) Inc

    Wuxi Biologics (Cayman) Inc

    WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading glo...

    WuXi Biologics (stock code: 2269.HK), a Hong Ko...

    Filing Type:    PU
    Illumina, Inc.

    Illumina, Inc.

    A global leader in DNA sequencing and array-based technologies, Illumina is fuelin...

    A global leader in DNA sequencing and array-bas...

    Filing Type:    PU
    Fate Therapeutics, Inc.

    Fate Therapeutics, Inc.

    We are a biopharmaceutical company dedicated to the development of programmed cell...

    We are a biopharmaceutical company dedicated to...

    Filing Type:    PU
    Kamada Ltd.

    Kamada Ltd.

    Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indicatio...

    Kamada Ltd. is focused on plasma-derived protei...

    Filing Type:    PU
    Retrophin, Inc.

    Retrophin, Inc.

    We are a biopharmaceutical company focused on developing our pipeline featuring sp...

    We are a biopharmaceutical company focused on d...

    Filing Type:    PU
    GlycoMimetics, Inc.

    GlycoMimetics, Inc.

    At GlycoMimetics, we are committed to helping to make a difference in the lives of...

    At GlycoMimetics, we are committed to helping t...

    Filing Type:    PU
    Cue Biopharma, Inc.

    Cue Biopharma, Inc.

    Cue Biopharma is an innovative clinical stage immunotherapy company developing a n...

    Cue Biopharma is an innovative clinical stage i...

    Filing Type:    PU
    Tiziana Life Sciences plc

    Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biot...

    Tiziana Life Sciences is a dual-listed (NASDAQ:...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.